Profile

Kathryn M. Greven, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

75 Ratings
5 Comments

Kathryn M. Greven, M.D.

Professor,


Clinical Specialties

Carcinoma of the Eye and Ocular Adnexa, Gynecologic Malignancies, Head and Neck Cancers, Total Body Irradiation for Bone Marrow Transplants, General Radiation Oncology, Radiation Oncology

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-3600
Department: 336-713-3600

Email: kgreven@wakehealth.edu

Insurance Accepted »

Education & Training

  • A.B., Duke University , 1979
  • M.D., WFU School of Medicine , 1983
  • Residency, North Carolina Baptist Hospita, 1987

Memberships

  • Am Medical Assn
  • Am Radium Society
  • Am Soc Of Clinical Oncology
  • Am Soc Of Ther Rad & Oncology
  • Forsyth-Davie-Stokes Medical S

NPI Number

  • 1972585339
Kathryn M. Greven, M.D.

Doctor Rating

4.7 out of 5

75 Ratings
5 Comments

Kathryn M. Greven, M.D.

Professor, Radiation Oncology
Comprehensive Cancer Center
Otolaryngology

Research Interests

cancer/oncogenesis, drugs/therapeutic agents pharm

Contact Information

Academic: 336-713-3600 | Department: 336-713-3600

Email: kgreven@wakehealth.edu

Recent Publications

Lee LJ, Ratner E, Uduman M, Winter K, Boeke M, Greven KM, King S, Burke TW, Underhill K, Kim H, Boulware RJ, Yu H, Parkash V, Lu L, Gaffney D, Dicker AP, Weidhaas J. The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905. PLoS One. 2014;9(4):e94167.

Klopp A, Smith BD, Alektiar K, Cabrera A, Damato AL, Erickson B, Fleming G, Gaffney D, Greven K, Lu K, Miller D, Moore D, Petereit D, Schefter T, Small W Jr, Yashar C, Viswanathan AN. The role of postoperative radiation therapy for endometrial cancer: executive summary of an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol. 2014;4(3):137-144.

Garg S, Kilburn JM, Randolph DM, Lucas JT, Urbanic JJ, Porosnicu M, Hinson WH, Kearns WT, Greven KM. Re-irradiation for second primary or recurrent cancers of the head and neck: composite dosimetric measures to evaluate dose to the carotid arteries [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S480-S481.

Rustin GJS, Vergote I, Eisenhauer E, Pujade-Lauraine E, Quinn M, Thigpen T, du Bois A, Kristensen G, Jakobsen A, Greven K, et al. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Int J Gynecol Cancer. 2011;21(2):419-423.


Lee LJ, Winter K, Ratner E, Greven KM, King S, Burke TW, Underhill K, Kim H, Boulware RJ, Weidhaas J. The KRAS-variant and outcome in endometrial adenocarcinoma: combined analysis of RTOG 9708 and 9905 [abstract]. Int J Radiat Oncol Biol Phys. 2010;78(3 Suppl):S402.

Saconn PA, Gee CJ, Greven CM, McCoy TP, Ekstrand KE, Greven KM. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study. Int J Radiat Oncol Biol Phys. 2010;78(3):844-848.

Greven KM. Resolving the confusion surrounding adjuvant radiation in endometrial cancer [commentary]. Oncology (Williston Park). 2009;23(4):353,356.

Greven K. Can serial PET/CT imaging during and after chemoradiation treatment assist in individualizing therapy for patients with squamous cell cancer of the head and neck? [abstract]. J Clin Oncol. 2009;27(15 Suppl):e17022.

Greven KM, Williams DW III, Browne JD, McGuirt WF Sr, White DR, D'Agostino RB Jr. Radiographic complete response on post treatment CT imaging eliminates the need for adjuvant neck dissection after treatment for node positive head and neck cancer. Am J Clin Oncol. 2008;31(2):169-172.

Greven KM, White DR, Browne JD, Williams DW III, McGuirt WF Sr, D'Agostino RB Jr. Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma. Am J Clin Oncol. 2008;31(3):209-212.

Zempolich K, Fuhrman C, Milash B, Flinner R, Greven K, Ryu J, Forbes A, Kerlin K, Nichols RC, Gaffney DK. Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: a microarray study of RTOG C-0128. Gynecol Oncol. 2008;109(2):275-279.

Saconn PA, Greven K, Gee C, Greven C, McCoy T, Ekstrand K. Alternative dose for choroidal melanoma treated with an iodine 125 radioactive plaque: a single institution retrospective study [abstract]. Int J Radiat Oncol Biol Phys. 2008;72(1 Suppl):S415-S416.

Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Greven K. A phase II study of acute toxicity for celebrex (TM) (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128. Int J Radiat Oncol Biol Phys. 2007;67(1):104-109.

Greven KM, Greven CM. Orbital, ocular, and optic nerve tumors In: Gunderson LL, Tepper JE, eds. Clinical radiation oncology. 2nd ed. Philadelphia: Elsevier Churchill Livingstone;2007: 613-628.

Lee WR, Bae K, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of radiation therapy oncology group study 0019. Cancer. 2007;109(8):1506-1512.

Small W, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, Erickson B, Jhingran A, Greven K. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys. 2007;68(4):1081-1087.

Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Small W, Greven K. Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. Int J Radiat Oncol Biol Phys. 2007;69(1):111-117.

Small W, Winter K, Levenback C, Iyer R, Hymes S, Jhingren A, Gaffney D, Erickson B, Greven K. Extended field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of Arm 2 of RTOG 0116 [abstract]. Int J Radiat Oncol Biol Phys. 2007;69(3 Suppl):S5-S6.


Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Greven K. Celebrex (Celecoxib) and chemoradiation in patients with locally advanced cervical cancer. An efficacy report of RTOG 0128 [abstract]. Int J Radiat Oncol Biol Phys. 2006;66(3 Suppl):S41.

Greven KM, Williams WD, Browne JD, McGuirt WF, D'Agostino R Jr. Complete clinical response on post treatment CT imaging eliminates the need for adjuvant neck dissection following treatment for node positive head and neck cancer [abstract]. Int J Radiat Oncol Biol Phys. 2006;66(3 Suppl):S440.

Lee W, Bae K, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Greven K, Kuettel M, Sandler H. Biochemical recurrence and late toxicity following external beam radiotherapy combined with permanent source prostate brachytherapy: analysis of RTOG 0019 [abstract]. Int J Radiat Oncol Biol Phys. 2006;66(3 Suppl):S57.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Radiation Oncology

Clinical Specialties

Carcinoma of the Eye and Ocular Adnexa, Gynecologic Malignancies, Head and Neck Cancers, Total Body Irradiation for Bone Marrow Transplants, General Radiation Oncology, Radiation Oncology
Kathryn M. Greven, M.D.

Kathryn M. Greven, M.D.

Professor, Radiation Oncology
Comprehensive Cancer Center
Otolaryngology

Doctor Rating

4.7 out of 5

Kathryn M. Greven, M.D.75 Ratings
5 Comments

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.7
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.8
Time CP spent with patient
4.7
Wait time at clinic
4.3



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

6/10/2014

#8. Plenty of time.

5/9/2014

They was very nice. They answered every question that we ask.

5/5/2014

Always good.

4/4/2014

*Dr. Greven was respectful and calm in her approach to my issues and to the discussion we had. I was confident in what she had to say.

3/17/2014

She is the best and I wouolodn't want anyone else tending to me care.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.